Treatment News

POZ - Health, Life and HIV
Subscribe to:
POZ magazine
Join POZ: Facebook MySpace Twitter Pinterest
Tumblr Google+ Flickr MySpace
POZ Personals
Sign In / Join

Back to home » Treatment News

October 29, 2014
High Efficacy Halts Placebo Phase of Intermittent PrEP Study
A study of intermittent dosing of Truvada as PrEP among gay and bi men has been stopped due to the intervention's high efficacy in preventing HIV.
October 28, 2014
Calculating PrEP’s Capacity to Prevent HIV in the Real World
The cost-effectiveness and capacity to prevent HIV among gay and bi men of Truvada as pre-exposure prophylaxis (PrEP) varies widely depending on various factors.
October 27, 2014
Inflammation May Lead to Diabetes in People on HIV Meds
There is a link between low-level elevations of markers indicating systemic inflammation and the development of type 2 diabetes among HIV-positive people taking antiretrovirals. 
October 23, 2014
More Than 4 Million People Over 50 Are Living With HIV Worldwide
Out of 35 million people living with HIV around the world, an estimated 4.2 million are older than 50.
October 22, 2014
Core-Antigen Tests Reliably Detect Acute Hep C in People With HIV
Using hepatitis C core-antigen testing to screen for acute cases among HIV-positive people is reliable and saves resources compared with PCR testing.
New HIV Drug Resistance Test Works With Undetectable Viral Load
LabCorp and Monogram Biosciences have developed a new test to detect HIV resistance mutations to antiretrovirals. Unlike previous tests, this one works even when an individual has a very low or undetectable viral load.
October 21, 2014
High Efficacy for PrEP Among Gay Men in English Study
Interim results of an English study of PrEP among gay and bi men and transgender women have shown high efficacy in preventing HIV.
October 20, 2014
STIs and HIV Are on the Rise in London Gay Men
Gay and bisexual men in London, England, are in the middle of rising twin epidemics of HIV and sexually transmitted infections.
October 17, 2014
Program Ups Viral Suppression Rates and Retention in HIV Care
A comprehensive care program used in New York City improves HIV-positive people’s retention in care and their rate of viral suppression.
October 16, 2014
Has Treatment Access Changed HIV Stigma in Uganda?
Perceived HIV stigma has risen in Uganda in recent years, while expressed attitudes toward people living with the virus have improved.
October 15, 2014
Coffee, Even Decaf, May Promote Liver Health
Drinking coffee, whether decaffeinated or regular, is linked to healthier levels on tests indicating liver function.
HIV Meds Can Benefit Positive Gay Meth and Cocaine Users
HIV-positive gay men and who use stimulants such as methamphetamine or cocaine can benefit significantly from HIV treatment.
October 14, 2014
HIV Can Infect Entire Female Reproductive Tract
HIV can apparently infect cells throughout the entire female reproductive tract, according to primate research.
October 13, 2014
Only 44 Percent of HIV-Diagnosed Latinos Are on Treatment
Less than half of all Latinos diagnosed with HIV are receiving antiretroviral treatment, according to the CDC.
October 10, 2014
Sustiva (Efavirenz)-Free First-Line HIV Regimens Work Well
A trio of Sustiva (efavirenz)-free combinations of antiretrovirals each worked well as a first-line treatment for HIV, although there were differences in tolerability.
October 09, 2014
New Technologies Provide Real-Time View of HIV on the Prowl
A new imaging technique has allowed researchers to observe the “dance” HIV undergoes as it prepares to infect a cell, an advancement that may open doors for developing new ways of preventing infection.
October 08, 2014
People With HIV and Kidney Problems Should Avoid Viread (Tenofovir)
While antiretroviral therapy is beneficial for HIV-positive people with reduced kidney function, they should not take Viread (tenofovir).
October 07, 2014
HIV Rebounds in Second Child Thought to Be Cured
Echoing the disappointment of the “Mississippi baby” case, a second child's virus has rebounded  after he was suspected to be functionally cured of HIV.
October 06, 2014
HIV Likely Spread Out of Kinshasa, the Congo, in 1920s
A new study argues that HIV initially spread from its more localized origins in central Africa out of Kinshasa, the capital of the Democratic Republic of the Congo.
Herbals and Supplements May Cause Liver Damage, Even Death
Herbals and dietary supplements (HDS) may be more dangerous to the liver than bodybuilding HDS or medications.
October 03, 2014
Gay Men, With or Without HIV, May Benefit From HPV Vaccine
Forty-seven percent of HIV-positive gay men and 64 percent of HIV-negative gay men in an Irish study would benefit from the human papillomavirus (HPV) vaccine
October 02, 2014
HIV May Replicate in Spinal Fluid Even After Years of Treatment
Low levels of HIV may still replicate in cerebrospinal fluid even when the viral load is undetectable in both the CSF and the plasma and after an individual has been treated with antiretrovirals for up to a decade.
October 01, 2014
Failed Pediatric HIV Vaccines May Offer Protection After All
Vaccines that have previously failed to demonstrate efficacy in preventing pediatric HIV transmission may work after all, thanks to insights gained from subsequent vaccine research.
More Treatment News

Have news about HIV? Send press releases, news tips and other announcements to

Most Popular Lessons

The HIV Life Cycle


Herpes Simplex Virus

Syphilis & Neurosyphilis

Treatments for Opportunistic Infections (OIs)

What is AIDS & HIV?

Hepatitis & HIV

15 Years Ago In POZ

Facebook Twitter Google+ MySpace YouTube Tumblr Flickr Instagram
Quick Links
Current Issue

HIV Testing
Safer Sex
Find a Date
Newly Diagnosed
HIV 101
Disclosing Your Status
Starting Treatment
Help Paying for Meds
Search for the Cure
POZ Stories
POZ Opinion
POZ Exclusives
Read the Blogs
Visit the Forums
Job Listings
Events Calendar
POZ on Twitter

Ask POZ Pharmacist

Talk to Us
Have you ever been diagnosed with diabetes or pre-diabetes?

Pop Watch

more surveys
Contact Us
We welcome your comments!
[ about Smart + Strong | about POZ | POZ advisory board | partner links | advertising policy | advertise/contact us | site map]
© 2014 Smart + Strong. All Rights Reserved. Terms of use and Your privacy.
Smart + Strong® is a registered trademark of CDM Publishing, LLC.